Plasma levels of α1-antitrypsin-derived C-terminal peptides in PiMM and PiZZ COPD patients
Friedemann R. Börner,
Urszula Lechowicz,
Sabine Wrenger,
Beatriz Martinez-Delgado,
Beata Olejnicka,
Tobias Welte,
Joanna Chorostowska-Wynimko,
Michael Kiehntopf,
Sabina Janciauskiene
Affiliations
Friedemann R. Börner
Institute of Clinical Chemistry and Laboratory Diagnostics, Jena University Hospital, Jena, Germany
Urszula Lechowicz
Department of Genetics and Clinical Immunology, National Institute of Tuberculosis and Lung Diseases Warsaw, Poland, Poland
Sabine Wrenger
Department of Respiratory Medicine and Infectious Diseases, Hannover Medical School, Biomedical Research in Endstage and Obstructive Lung Disease Hannover BREATH, German Center for Lung Research DZL, Hannover, Germany
Beatriz Martinez-Delgado
Molecular Genetics Unit, Institute of Rare Diseases Research (IIER), CIBER of Rare Diseases (CIBERER), Institute of Health Carlos III (ISCIII), Madrid, Spain
Beata Olejnicka
Department of Respiratory Medicine and Infectious Diseases, Hannover Medical School, Biomedical Research in Endstage and Obstructive Lung Disease Hannover BREATH, German Center for Lung Research DZL, Hannover, Germany
Tobias Welte
Department of Respiratory Medicine and Infectious Diseases, Hannover Medical School, Biomedical Research in Endstage and Obstructive Lung Disease Hannover BREATH, German Center for Lung Research DZL, Hannover, Germany
Joanna Chorostowska-Wynimko
Department of Genetics and Clinical Immunology, National Institute of Tuberculosis and Lung Diseases Warsaw, Poland, Poland
Michael Kiehntopf
Institute of Clinical Chemistry and Laboratory Diagnostics, Jena University Hospital, Jena, Germany
Sabina Janciauskiene
Department of Genetics and Clinical Immunology, National Institute of Tuberculosis and Lung Diseases Warsaw, Poland, Poland
